Mycophenolic Acid: all 424 studies that test it

Page 2 of 5. Open to participants first (37), then studies with results posted, then the rest; newest registration first within each.

• A Reduced Toxicity Allogeneic Unrelated Donor Stem Cell Transplantation (SCT) for Severe Sickle Cell DiseaseTerminatedNCT01279616Phase 2Results posted
• Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell TransplantCompletedNCT01251575Phase 2Results posted
• First-line Antimetabolites as Steroid-sparing Treatment Uveitis Pilot TrialCompletedNCT01232920Phase 3Results posted
• Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell TransplantCompletedNCT01231412Phase 3Results posted
• Mycophenolic Acid (MPA) Monotherapy in Liver TransplantationTerminatedNCT01230502Not applicableResults posted
• Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell TransplantTerminatedNCT01118013Phase 2Results posted
• Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT01093586Phase 2Results posted
• Calcineurin Inhibitor Sparing After Kidney TransplantationCompletedNCT01062555Phase 1/2Results posted
• Mycophenolic Acid Monotherapy in Recipients of HLA-identical Living-Related TransplantationTerminatedNCT01053221Phase 2Results posted
• Allogeneic Bone Marrow Transplant for Inherited Metabolic DisordersCompletedNCT01043640Phase 2Results posted
• A Pharmacokinetic Study of CellCept (Mycophenolate Mofetil) Versus Mycophenolate Sodium in Kidney Transplant PatientsCompletedNCT01033864Phase 4Results posted
• Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesTerminatedNCT01028716Phase 2Results posted
• Everolimus in de Novo Heart Transplant RecipientsCompletedNCT01017029Phase 4Results posted
• A Study of Mycophenolate Mofetil (CellCept) in Lung Transplant RecipientsCompletedNCT01014442Phase 3Results posted
• Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic LeukemiaCompletedNCT01008462Phase 2Results posted
• Sirolimus Conversions in African-American Renal Transplant RecipientsCompletedNCT01005706Not applicableResults posted
• Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)CompletedNCT01002742Phase 3Results posted
• Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant PatientsTerminatedNCT00991510Phase 4Results posted
• Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With LymphomaCompletedNCT00928018Phase 3Results posted
• Mycophenolate Mofetil 250 mg Capsules Under Fasting ConditionsCompletedNCT00911274Phase 1Results posted
• Mycophenolate Mofetil 250 mg Capsules Under Fed ConditionsCompletedNCT00910663Phase 1Results posted
• Mycophenolate Mofetil Tablets Under Fed ConditionsCompletedNCT00908128Phase 1Results posted
• Mycophenolate Mofetil Tablets Under Fasting ConditionsCompletedNCT00907907Phase 1Results posted
• Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II)CompletedNCT00883129Phase 2Results posted
• Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous GlomerulonephritisCompletedNCT00843856Phase 4Results posted
• Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic MalignanciesCompletedNCT00795132Phase 2Results posted
• Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic CancerCompletedNCT00789776Phase 1/2Results posted
• Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic CancerCompletedNCT00782379Phase 2Results posted
• Trial Of Double Umbilical Cord Blood TransplantationCompletedNCT00763490Phase 2Results posted
• Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic CancerCompletedNCT00723099Phase 2Results posted
• Steroid Withdrawal in Pediatric Renal Transplant: Impact on Growth, Bone Metabolism and Acute RejectionCompletedNCT00707759Phase 3Results posted
• A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV)CompletedNCT00683930Phase 3Results posted
• A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal SymptomsTerminatedNCT00658333Phase 4Results posted
• Small Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept®CompletedNCT00652834Phase 4Results posted
• Allogeneic Hematopoietic Cell Transplantation for Severe Systemic SclerosisCompletedNCT00622895Phase 1/2Results posted
• Biomarker-Linked Outcomes of Cellcept in Lupus ArthritisCompletedNCT00594932Phase 1/2Results posted
• Pharmacokinetic Profile of Myfortic in Combination With Tacrolimus in Fed Versus Fasting StateCompletedNCT00585468Phase 4Results posted
• Phase I/II Thymus Transplantation With Immunosuppression #950CompletedNCT00579527Phase 1/2Results posted
• Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin LymphomaCompletedNCT00574496Phase 2Results posted
• Enteric-coated Mycophenolate Sodium (Myfortic®) in Heart Transplant RecipientsCompletedNCT00574197Phase 4Results posted
• Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological MalignanciesCompletedNCT00566696Phase 2Results posted
• Improved Induction and Maintenance Immunosuppression in Kidney TransplantationCompletedNCT00556933Phase 4Results posted
• Belatacept in Liver Transplant RecipientsTerminatedNCT00555321Phase 2Results posted
• A Study of NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.CompletedNCT00551291Phase 2Results posted
• A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.CompletedNCT00545402Phase 4Results posted
• A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant RecipientsCompletedNCT00543569Phase 2Results posted
• Myfortic or CellCept Gastrointestinal Effects in African American Kidney RecipientsTerminatedNCT00522548Phase 4Results posted
• Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose RegimenCompletedNCT00514514Phase 3Results posted
• Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)TerminatedNCT00506948Phase 2Results posted
• Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's LymphomaTerminatedNCT00481832Phase 2Results posted
• A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney TransplantationCompletedNCT00455013Phase 2Results posted
• Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi AnemiaCompletedNCT00453388Phase 2Results posted
• Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.CompletedNCT00446459Phase 2Results posted
• Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal TransplantCompletedNCT00446251Phase 2Results posted
• Efficacy and Safety Study of Abatacept to Treat Lupus NephritisTerminatedNCT00430677Phase 2/3Results posted
• A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.TerminatedNCT00425438Phase 3Results posted
• Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis FlareCompletedNCT00423098Phase 2Results posted
• A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis.CompletedNCT00377637Phase 3Results posted
• Study of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid WithdrawalCompletedNCT00374803Phase 4Results posted
• Single Center Pilot Study of Corticosteroid Discontinuation in Liver Transplant RecipientsCompletedNCT00374231Phase 4Results posted
• Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited DisordersTerminatedNCT00358657Phase 2Results posted
• Hematopoietic Stem Cell Transplantation in the Treatment of Infant LeukemiaCompletedNCT00357565Phase 2Results posted
• TBI Dose De-escalation for Fanconi AnemiaCompletedNCT00352976Phase 2/3Results posted
• Conversion of CellCept to Myfortic: A Prospective Study in Liver Transplant RecipientsCompletedNCT00336895Not applicableResults posted
• A Prospective Study on the Tolerability and Efficacy of the de Novo Use of Myfortic in Liver Transplant RecipientsCompletedNCT00336817Not applicableResults posted
• Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung InvolvementCompletedNCT00333437Not applicableResults posted
• Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous LeukemiaCompletedNCT00322101Phase 3Results posted
• Mycophenolate Mofetil (MMF) in Patients With IgA NephropathyTerminatedNCT00318474Phase 3Results posted
• Allogeneic Bone Marrow Transplantation Using Less Intensive TherapyTerminatedNCT00303719Phase 2Results posted
• Rheumatoid Arthritis:Tolerance Induction by Mixed ChimerismTerminatedNCT00282412Phase 1Results posted
• Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic CancerTerminatedNCT00255684Not applicableResults posted
• Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation RecipientsCompletedNCT00240994Phase 2Results posted
• Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302)CompletedNCT00224874Phase 2Results posted
• Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver TransplantationCompletedNCT00206076Phase 4Results posted
• Allogeneic Transplantation From Related Haploidentical DonorsCompletedNCT00185692Phase 2Results posted
• Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple MyelomaCompletedNCT00185614Phase 2Results posted
• Stem Cell Transplant for Immunologic or Histiocytic DisordersCompletedNCT00176865Phase 2Results posted
• Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C InfectionCompletedNCT00163657Phase 4Results posted
• Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT)CompletedNCT00135811Phase 3Results posted
• Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic SyndromeTerminatedNCT00119366Phase 2Results posted
• Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00118352Phase 2Results posted
• Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerCompletedNCT00112593Not applicableResults posted
• Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)TerminatedNCT00089141Phase 3Results posted
• Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic CancerCompletedNCT00089011Phase 2Results posted
• Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's LymphomaTerminatedNCT00057954Phase 2Results posted
• Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple MyelomaCompletedNCT00054353Phase 1/2Results posted
• NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/DisordersCompletedNCT00053989Phase 2Results posted
• S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid LeukemiaTerminatedNCT00053014Phase 2Results posted
• Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancerCompletedNCT00049504Phase 2Results posted
• Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in RemissionCompletedNCT00045435Phase 2Results posted
• Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic SyndromesCompletedNCT00045305Phase 2Results posted
• Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory LymphomaCompletedNCT00005803Phase 1/2Results posted
• Treatment Strategies in IgG4-RD Patients With Re-elevation of Serum IgG4 Level During Maintenance Remission PeriodStatus unknownNCT05974683Not applicable
• An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity PneumonitisActive, not recruitingNCT05626387Phase 4
• Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory CardiomyopathyTerminatedNCT05570409Phase 2/3
• Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic SyndromeActive, not recruitingNCT05457556Phase 3
• KidneyCare Immuno-optimization in Renal Allografts (KIRA)WithdrawnNCT05423496Not applicable
• Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic DisordersWithdrawnNCT05293509Phase 2
• Micophenolate Mofetil Versus Azathioprine in MyocarditisCompletedNCT05237323Phase 3
• Tacrolimus Versus Mycophenolate for Autoimmune Hepatitis Patients With Incomplete Response on First Line TherapyStatus unknownNCT05221411Phase 4

← Mycophenolic Acid overview